The biotechnology company disclosed interim human trial data for its RV-001 optogenetic treatment aiming to restore sight in ...

The PRIME status for RTx-015 was granted based on preliminary Phase I/II safety and efficacy clinical data.

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

Researchers are pushing the boundaries of what “restoring sight” can mean, not only through surgical implants or gene editing but also through software that reshapes how the brain interprets what the ...

Please provide your email address to receive an email when new articles are posted on . Optometrists sometimes suggest vision therapy to improve visual skills, addressing perceptual vision and myopia.

With a multi-institutional team of engineers, optometrists, vision researchers, sports medicine physicians and biostatisticians, NJIT's Tara Alvarez set out four years ago to gather data that could ...